Open AccessOutcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis
Author(s) -
Daniel Ryan,
Laura F. Newell,
Ellen K. Ritchie,
Stephen A. Strickland,
Donna E. Hogge,
Scott R. Solomon,
Gary J. Schiller,
Matthew J. Wieduwilt,
Robert J. Ryan,
Stefan Faderl,
Jorge E. Cortés
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.073
Subject(s) - medicine , cytarabine , induction chemotherapy , daunorubicin , gastroenterology , chemotherapy regimen , myeloid leukemia , oncology , leukemia , surgery , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom